Ointment Gel & Cream
Approved Ointment, Gel & Cream Formulations
Meeting Global Pharmaceutical Product Standards
S.No. | Product | Composition |
---|---|---|
1. | AciclovirCream IP 5.0% w/w | Composition: Aciclovir IP 5%w/w In a cream base q.s. |
2. | Azelaic Acid Gel 15% w/w | Composition: Azelaic Acid 15%w/w In a gel base q.s. |
3. | Beclomethasone Dipropionate and SalicylicAcid ointment | Composition: BeclomethasoneDipropionate IP 0.025% w/w Salicylic Acid I.P 3.0%w/w In an ointment base q.s |
4. | Beclomethasone Dipropionate,Clotrimazoleand NeomycinSulphateCream | Composition: Beclomethasone Dipropionate IP 0.025% w/w Clotrimazole IP 1.00%w/w Neomycin Sulphate IP Equivalent to Neomycinbase 0.5%w/w In a Cream Base q.s |
5. | Beclomethasone Dipropionate,Neomycin sulphate cream | Composition: Beclomethasone Dipropionate IP 0.025% w/w Neomycin sulphate IP Equivalent to Neomycin base 0.5%w/w In a cream base q.s |
6. | Ciprofloxacin hydrochloride Metronidazole,Terbinafine hydrochloride and ClobetasolPropionate cream | Composition: Ciprofloxacin hydrochloride IP 1.0%w/w Metronidazole IP 1.0 %w/w Terbinafine hydrochloride IP 1.0%w/w Clobetasolpropionate IP 0.05%w/w In a Cream Base q.s. |
7. | Clobetasol Propionate cream IP 0.05% w/w | Composition: ClobetasolPropionate IP 0.05%w/w In a Cream Base q.s. |
8. | Clobetasol PropionateN, eomycin Sulphate Miconazole Nitrate Cream | Composition: Clobetasol Propionate IP 0.05%w/w NeomycinSulphate IP eq.to Neomycin 0.5%w/w Miconazole Nitrate IP 2.0%w/w In a cream Base q.s |
9. | Clobetasol Propionate,Gentamicin,Tolnafte, Iodochlorhydroxyquinoline and Clotrimazole cream | Composition: Clobetasol Propionate IP0.05% w/w Gentamicin Sulphate IP Equivalent to Gentamicin 0.10%w/w Tolnaftate IP 1.00%w/w Iodochlorhydroxyquinoline IP 1.00%w/w Clotrimazole IP 1.00%w/w In a cream base q.s. |
10. | Clobetasol Propionate,Neomycin Sulphate Tolnaftate,Iodochlorhydroxyquinoline and Ketoconazole cream | Composition: Clobetasol Propionate BP 0.05%w/w Neomycin Sulphate IP eq.to Neomycin 0.10%w/w Tolnaftate IP 1.00%w/w Iodochlorhydroxyquinoline IP 1.00%w/w Ketoconazole IP 2.00 % w/w Inacreambase q.s. |
11. | Clotrimazole Cream IP 1.0% w/w | Composition: Clotrimazole IP 1.0%w/w In a cream base q.s. |
12. | Diclofenac Gel IP | Composition: Diclofenac Diethylamine IP 1.16%w/w Equivalent to Diclofenac Sodium 1%w/w in a gel base q.s. |
13. | Fusidic Acid Cream IP 2% w/w | Composition: Fusidic Acid IP equivalent to anhydrous Fusidic acid 2.0 %w/w Ina water miscible Cream base q.s |
14. | Glycolic Acid Cream 6%w/w | Composition: Glycolic Acid 6%w/w In a cream base q.s |
15. | Glycolic Acid Cream 12%w/w | Composition: Glycolic Acid 12%w/w In a cream base q.s |
16. | Hydroquinone cream USP 4%w/w | Composition: Hydroquinone USP 4% w/w In a cream base q.s. |
17. | Hydroquinone, Tretinoin and Mometasone Furoate Cream | Composition: Hydroquinone IP 2.0%w/w Tretinoin USP 0.025%w/w Mometasone Furoate IP 0.1%w/w In a cream base q.s. |
18. | Itraconazole,Ofloxacin,Ornidazole, Clobetasol propionate Cream | Composition: Itraconazole IP 1.0%w/w Ofloxacin IP 0.75%w/w Ornidazole IP 2.0%w/w Clobetasol propionate IP 0.05 % w/w In a cream base q.s. |
19. | Miconazole Nitrate cream IP2%w/w | Composition: MiconazoleNitrate IP 2% w/w Water Miscible Base q.s. |
20. | NadifloxacinCream IP 1% w/w | Composition: Nadifloxacin IP 1% w/w In a cream base q.s. |
21. | Povidone iodine ointment USP | Composition: Povidone IP 10%w/w (1.0 %w/w Available lodine) Water soluble ointment base q.s |
22. | Povidone iodine ointment USP | Composition: Povidone-iodine IP 5.0% w/w (0.5%w/wAvailablelodine) Water soluble ointment base q.s. |
23. | Povidone-iodine Metronidazole and Dexpanthenol ointment. | Composition: Povidone-iodine IP 5.0% w/w(0.5%w/w Available lodine) Metronidazole IP 1.0%w/w Dexpanthenol BP 5.0% w/w Water soluble ointment base q.s. |
24. | Salicylic Acid ointment IP 6%w/w | Composition: SalicylicAcid IP 6% w/w in an ointment base q.s. |
25. | Salicylic Acid Gel 2% w/w | Composition: SalicylicAcid IP 2%w/w In a Gel Base q.s |
26. | Sertaconazole Nitrate Cream IP 2% w/w | Composition: SertaconazoleNitrate IP 2.0%w/w In a Cream Base q.s. |
27. | Silver Sulfadiazine and Chlorhexidine Gluconate Cream | Composition: SilverSulfadiazine IP 1.0%w/w ChlorhexidineGluconate Solution I.P Equivalent to chlorhexidine Gluconate 0.2% w/w Ina cream base q.s |
28. | Tacrolimus Ointment 0.1%w/w | Composition: Tacrolimus IP 0.1%w/w In an ointment Base q.s. |
29. | Terbinafine Hydrochloride Cream IP 1% w/w | Composition: TerbinafineHydrochloride IP 1.0%w/w In a cream base q.s. |
30. | Tranexamic Acid Cream 5% w/w | Composition: Tranexamic Acid IP 5%w/w In a cream base q.s. |
31. | Tretinoin and Clindamycin Phosphate Gel | Composition: Tretinoin USP 0.025% w/w Clindamycin Phosphate IP Equivalent to Clindamycin 1.0% w/w In a gel base q.s. |
32. | Gabapentin, ketoprofen, Capsaicin & methyl Salicylate Cream | Composition : Gabapentin IP 8 % w/w Ketoprofen IP 5 % w/w Capsaicin USP 0.035 % w/w Methyl Salicylate IP 5 % w/w Cream Base q.s |
33. | Halobetasol Propionate And Fusidic Acid Cream | Composition : Halobetasol Propionate USP Fusidic Acid IP In a Cream Base |
34 | Azelaic Acid Gel 10 % w/w | Composition: Azelaic Acid 10 % w/w In a gel base q.s. |
35 | Eberconazole 1% Cream | Composition : Eberconazole Nitrate IP equivalent to Eberconazole |
36 | Clobetasol Propionate and Salicylic Acid Ointment | Composition : Clobetasol Propionate IP Salicylic Acid IP In an Ointment base |
37 | Tretinoin ointment 0.025% w/w | Composition : Tretinoin USP In an Ointment base |
38 | Hydroquinone , Fluocinolone Acetonide and Tretinoin Ointment | Composition : Hydroquinone IP Fluocinolone Acetonide IP Tretinoin USP In an Ointment base |
39 | Permethrin Cream 5% w/w | Composition : Permethrin In a cream base |
40 | Light liquid Paraffin and White Soft Paraffin Cream | Composition : White Soft Paraffin IP Light liquid Paraffin IP In a cream base In a Cream Base |
41 | Hydroquinone , Tretinoin and Fluocinolone Acetonide Cream | Composition : Hydroquinone IP 4.00 % w/w Tretinoin USP 0.25 % w/w Fluocinolone Acetonide IP 0.01 % w/w In a Cream base q.s |
42 | Tranexamic Acid, Kojic Acid Dipalmitate, Alpha Arbutin, Mulberry Extract, Magnesium Ascorbyl Phosphate & Vitamin E Cream | Composition : Tranexamic Acid IP 10.0 % w/w Kojic Acid Dipalmitate 2.0 % w/w Alpha Arbutin 1.5 % w/w Mulberry Extract 1.0 % w/w Magnesium Ascorbyl Phosphate 1.0 % w/w Vitamin E Acetate IP 1.0 % w/w In a cream Base q.s |
43 | Azelaic acid and Tretinoin cream | Composition: Azelaic 10 % w/w Tretinoin USP 0.05 % w/w In a cream base q.s. |
44 | Chlorhexidine Gluconate Gel 1.0 % w/w | Composition: Chlorhexidine Gluconate Solution IP equivalent to Chlorhexidine Gluconate 1.0% w/w in pleasantly flavoured gel base |
45 | Choline Salicylate, Lignocaine Hydrochloride & Benzalkonium Chloride Gel | Composition: Choline Salicylate Solution BP Equivalent to Choline Salicylate 8.7% w/w Lignocaine Hydrochloride IP 2.0% w/w Benzalkonium Chloride IP 0.01% w/w |
46 | (As preservative) In pleasant flavoured gel base | |
47 | Metronidazole Gel IP 2% | Composition: Metronidazole IP 2% w/w In Water soluble Gel base q.s. |
48 | Metronidazole Gel IP 1% | Composition: Metronidazole IP 1% w/w In Water soluble Gel base q.s. |
49 | Metronidazole Gel IP 0.5 % | Composition: Metronidazole IP 0.5 % w/w In Water soluble Gel base q.s. |
50 | Metronidazole Gel IP 0.75 % | Composition: Metronidazole IP 0.75 % w/w In Water soluble Gel base q.s. |
51 | Calcium Dobesilate, Lignocaine, Hydrocortisone Acetate & Zinc Cream | Composition: Calcium Dobesilate Monohydrate IP Eq. to Anhydrous Calcium Dobesilate 0.25 % w/w Lignocaine Hydrochloride IP 3 % w/w Hydrocortisone Acetate IP 0.25 %w/w Zinc Oxide IP 5% w/w In a Cream base q .s |
52 | Nifedipine and Lignocaine Hydrochloride Gel | Composition: Nifedipine IP 0.3 %w/w Lignocaine Hydrochloride IP Eq. to Lignocaine 1.5 % w/w In a Cream base q.s. |
53 | Metronidazole & Chlorhexidine Gluconate gel | Composition: Metronidazole I.P Chlorhexidine Gluconate Solution Eq. to Chlorhexidine Gluconate In a gel base |
54 | Benzalkonium Chloride, Choline Salicylate Gel | Composition: Choline Salicylate Solution B.P. eq. to Choline Salicylate 8.7 % w/w Benzalkonium Chloride solution IP 0.01 % w/w In Pleasant flavoured gel base q.s |
55 | Nadifloxacin gel I.P. 1% w/w | Composition: Each gm of gel contains Nadifloxacin IP 10 mg In a gel base q.s. |
56 | Povidone-lodine Solution IP 5 % | Composition: Povidone-lodine IP 5 % w/v (available lodine 0.5 % w/v) Purified Water q.s |
57 | Povidone-lodine Solution IP 7.5 % | Composition: Povidone-lodine IP 7.5 % w/v (available lodine 0.75 % w/v) Purified Water q.s |
58 | Povidone-lodine Solution IP 10 % | Composition: Povidone-lodine IP 10 % w/v (available lodine 1.0 % w/v) Purified Water q.s |
59 | Triamcinolone Acetonide Oromucosal Paste BP 0.1 % w/w | Composition: Triamcinolone Acetonide IP 0.1% w/w Oromucosal Paste q.s. |
60 | Hydroquinone , Fluocinolone Acetonide and Tretinoin Cream | Composition : Hydroquinone USP 2.0 % w/w Fluocinolone Acetonide IP 0.01% w/w Tretinoin USP 0.025% w/w In an Cream base q.s |
61 | Hydroquinone , Fluocinolone Acetonide and Tretinoin Cream | Composition : Hydroquinone USP 4.0 % w/w Fluocinolone Acetonide IP 0.01 % w/w Tretinoin USP 0.05% w/w In an Cream base q.s |
62 | Hydrocortisone 1% w/w Cream IP | Composition: Hydrocortisone Acetate IP 1 % w/w Cream base q.s. |
63 | Glycolic Acid , Alpha Arbutin and Kojic Acid Dipalmitate Cream | Composition : Glycolic Acid 10 % w/w (As glycolic acid solution) Alpha Arbutin 5 % w/w Kojic Acid Dipalmitate 2.0 % w/w In a cream Base q.s |
64 | Octinoxate, Glycolic Acid, Kojic Acid Dipalmitate, Grape Seed Oil, Arbutin, Mulberry Extract, Vitamin E Allantoin Gel | Composition: Octinoxate 7.50 % w/w Glycolic Acid 3.00 % w/w (added as Glycolic Acid 70% Solution) Kojic Acid Dipalmitate 2.50% w/w Grape Seed Oil 2.00 % w/w Alpha Arbutin 1.50 % w/w Mulberry Extract 1.00 % w/w Vitamin E IP 1.00 %w/w Allantoin 0.4 % w/w In a Gel Base |
65 | Lidocaine Hydrochloride, Gabapentin & Baclofen Gel | Composition: IP 6.00 % w/w Lidocaine Hydrochloride Gabapentin IP 5.00 % w/w Baclofen IP 2.00 % w/w In a gel Base q.s |
66 | Diltiazem Hydrochloride Gel 2% w/w | Composition: Diltiazem Hydrochloride I.P. 2 % W/W In a Gel base q.s. |
67 | Diltiazem Hydrochloride and Lidocaine Hydrochloride Gel | Composition: Diltiazem Hydrochloride IP 2 % W/W Lidocaine Hydrochloride IP 2 % w/w Gel base q.s. |
68 | Heparin Sodium & Benzyl Nicotinate Ointment | Composition: Each gm contains: Heparin Sodium IP 50 IU Benzyl Nicotinate 2 mg In an Ointment base q s. |
69 | Clobetasol Propionate, Gentamycin , Tolnaftate , Iodochlorhydroxyquinoline, and Clotrimazole Cream | Composition: Clobetasol Propionate IP 0.05 % w/w Gentamycin Sulphate IP Eq. to Gentamycin 0.10 % w/w Tolnaftate IP 1.0 % w/w Iodochlorhydroxyquinoline IP 1.0 % w/w Clotrimazole IP 1.0 % w/w In a cream Base q.s |
70 | Clobetasol Propionate, Neomycin Sulphate , Tolnaftate , Iodochlorhydroxyquinoline, and Ketoconazole Cream | Composition: Clobetasol Propionate IP 0.05 % w/w |
71 | Neomycin Sulphate IP Eq. to Neomycin 0.10 % w/w Tolnaftate IP 1.0 % w/w Iodochlorhydroxyquinoline IP 1.0 % w/w Ketoconazole IP 2.0 % w/w In a cream Base q.s | |
72 | Ciclopirox Olamine Cream U.S.P.1.0 % w/w | Composition: Ciclopirox Olamine USP 1.0 % w/w Excipients q.s In a cream Base |
73 | Ciprofloxacin hydrochloride Metronidazole, Terbinafine hydrochloride and Clobetasol Propionate cream | Composition: Ciprofloxacin hydrochloride IP 1.0% w/w Metronidazole IP 2.0 % w/w Terbinafine hydrochloride IP 1.0% w/w Clobetasol propionate IP 0.05% w/w In a Cream Base q.s. |
74 | Desonide Cream 0.05% w/w | Composition: Desonide USP 0.05 % w/w In a Cream Base q.s. |
75 | Neomycin Sulphate and Miconazole Nitrate Cream | Composition: Miconazole Nitrate IP 2.0%w/w Neomycin Sulphate IP Eq. to Neomycin 0.50 % w/w In a cream Base q.s |
76 | Diclofenac Diethylamine , Methyl Salicylate and Menthol gel | Composition: Diclofenac Diethylamine IP 2.32 % w/w Equivalent to Diclofenac Sodium IP 2.0 % w/w Menthol IP 5.0 % w/w Methyl Salicylate IP 10.0 % w/w in a gel base q.s. |
77 | Sertaconazole Nitrate and Beclomethasone Dipropionate Cream IP | Composition: Sertaconazole Nitrate IP 2.0% w/w Beclomethasone Dipropionate IP 0.025% w/w In cream base q.s |
78 | Ozenoxacin cream 1 % w/w | Composition: Ozenoxacin 1.0% w/w In cream base q.s |
79 | Pramoxine Hydrochloride Cream USP | Composition: Pramoxine Hydrochloride USP 1.0% w/v Excipients q.s In cream base |
80 | Ciclopirox Olamine Cream USP 1.0 % w/w | Composition: Ciclopirox Olamine USP 1.0% w/v Excipients q.s In a cream base |
81 | Diclofenac Diethylamine, Virgin Linseed Oil, Methyl Salicylate, & Menthol Gel | Composition: Diclofenac Diethylamine IP 1.16 % w/w Eq. to Diclofenac Sodium IP 1.00 % w/w Virgin Linseed Oil BP 3.00 % w/w Methyl Salicylate IP 10.00 % w/w Menthol IP 0.5 % w/w Benzyl Alcohol IP 1.00 % w/w (As Preservative) Gel base q.s |
82 | Diclofenac Diethylamine, Methyl Salicylate, Oleum Lini & Menthol Gel | Composition: Diclofenac Diethylamine IP 1.16 % w/w Eq. to Diclofenac Sodium IP 1.00 % w/w Methyl Salicylate IP 10.00 % w/w Oleum Lini BP 3.00 % w/w Menthol IP 5.00 % w/w Benzyl Alcohol IP 1.00 % w/w (As Preservative) Gel base q.s |
83 | Pregabalin, Diclofenac Diethylamine, Methyl Salicylate, Capsaicin & Menthol Gel | Composition: Pregabalin IP 8.00 % w/w Diclofenac Diethylamine IP Eq. to Diclofenac Sodium IP 5.00 % w/w Methyl Salicylate IP 10.00 % w/w Menthol IP 5.00 % w/w Capsaicin USP 0.035 % w/w Benzyl Alcohol IP 1.00 % w/w (As Preservative) In aqueous Gel base q.s |
84 | Beclomethasone Dipropionate, Phenylephrine Hydrochloride, Lignocaine Hydrochloride Cream (Anti-Haemorrhoidal Cream with Beclomethasone Dipropionate) | Composition: Beclomethasone Dipropionate IP 0.025 % w/w Phenylephrine Hydrochloride IP 0.10 % w/w Lignocaine Hydrochloride IP 2.50 % w/w Chlorocresol IP q.s (As Preservative) In aqueous cream base |
85 | Precipitated Sulphur, Calamine & Zinc Oxide Lotion | Composition: Precipitated Sulphur IP 10 % w/v Calamine IP 15 % w/v Zinc Oxide IP 5 % w/v In a Lotion Base q.s |
86 | Desonide Lotion 0.05% w/w | Composition: Desonide USP 0.05 % w/w In Lotion Base q.s. |